Corrigendum: Zoledronate triggers Vδ2 T cells to destroy and kill spheroids of colon carcinoma: Quantitative image analysis of three-dimensional cultures [Front Immunol, 9, (2018), (998)] doi: 10.3389/fimmu.2018.00998

Research output: Contribution to journalComment/debatepeer-review

Abstract

There is an error in the Funding statement. The correct name for one of the funders is Ministero della Salute. The correct Funding statement is: This work has been partially supported by grants from AIRC to AP (IG15483) and AIRC to MZ (IG17074) and from 5xmille 2012 Ministero della Salute, 5xmille 2013 Ministero della Salute, 5xmille 2014 Ministero della Salute, and 5xmille 2015 Ministero della Salute to AP. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish
Article number1343
JournalFrontiers in Immunology
Volume9
Issue numberJUN
DOIs
Publication statusPublished - Jun 13 2018

Keywords

  • Antibody-dependent cellular cytotoxicity
  • CRC
  • Epidermal growth factor receptor
  • Spheroid
  • Zoledronate
  • γ T cells

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Corrigendum: Zoledronate triggers Vδ2 T cells to destroy and kill spheroids of colon carcinoma: Quantitative image analysis of three-dimensional cultures [Front Immunol, 9, (2018), (998)] doi: 10.3389/fimmu.2018.00998'. Together they form a unique fingerprint.

Cite this